Clinical trial

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

NCT05760248

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-05-04

PhasePHASE2

Study timeline

Study start (actual)2023-05-04Date precision: day

Registry last updated2025-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Subcutaneous Fat Disorderunresolved

Interventions

10XB-101 Solution for Injection, 6.0%DRUG

Placebo Solution for Injection (no active ingredient)DRUG

Sponsors & collaborators

10xBio, LLClead sponsor

Therapeutics, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05760248 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.